Skip to main content
Premium Trial:

Request an Annual Quote

Nils Hoem, Martin Maduas, Francis Lunger, and Philip Petraglia

Premium

MDS Pharma has appointed Nils Hoem as director of pharmacokinetics/pharmacodynamics in Europe, the company said last week.

Hoem will be responsible for managing a team of approximately 15 scientists located in MDS’ European clinical pharmacology units. Prior to joining MDS, Hoem ran his own business, Hoem Pharma Consulting. He was also employed by Smerud Medical Research Group and the University of Oslo. He holds a PhD in clinical pharmacokinetics and pharmacodynamics from the University of Oslo.


Millipore announced last week that its new president and CEO, Martin Maduas, will start on Jan. 1, 2005. He will also join Millipore’s board of directors at that time. Maduas is assuming the roles of president and CEO from Francis Lunger, who will remain as chairman of the board until March 1, 2005, Millipore said.


Philip Petraglia has become controller of the Pittsburgh Life Sciences Greenhouse, PLSG said last week. He joins the public/private biotech investment partnership from Resources Connection, a professional services firm. Petraglia holds a bachelor’s degree from Westminster College in New Wilmington, Pa.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.